On February 9, 2023, China Business Law Journal announced its "Deals of the Year 2022", which highlights 15 Han Kun-advised deals.
The legal market has shown great resolve and imagination in what has been another challenging year. In China and abroad, scores of representative deals have demonstrated lawyers' wisdom and work ethic. Some deals have turned the tide, some have saved the day, and some have offered hope for the coming year. Among the deals that have closed or have seen significant progress between November 1, 2021 and October 31, 2022, China Business Law Journal has selected the standouts as the Deals of the Year 2022 from a voluminous database of Chinese and international law firm submissions, saluting the hard work and remarkable performance behind each deal.
ECARX SPAC listing on Nasdaq
Huaxia CCCC REIT's USD1.3bn listing
KE Holdings' Hong Kong dual-primary listing
Leapmotor's USD800m HK listing
Li Auto's USD2bn follow-on offering
NIO's listing by introduction in HK, Singapore
Penghua Shenzhen Energy REIT's SZSE listing
Tims China lists via SPAC on Nasdaq
GAC Aion's series A financing
JD Property's mandatory acquisition of China Logistics
Abogen Biosciences series C, C+ financing
J&T Express USD1bn acquisition of Best
JD Property's USD800m series B financing
Wallaby Medical's acquisition of Phenox, Femtos
Wanda's transfer Legendary stake to Apollo
*The above deals are sourced from the China Business Law Journal website (https://www.vantageasia.com).
As in previous years, backed by its years of independent observation and continued coverage of China's legal market and following intensive research and extensive consultation, China Business Law Journal has selected the Deals of the Year 2022 by taking into account factors that included overall significance, complexity, innovative nature, and deal size, among other broader interests.
